Cleveland, OH- based Juventas Therapeutics, a clinical-stage regenerative medicine company, has closed a $22.2 million Series B financing that was co-led by Triathlon Medical Venture Partners and New Science Ventures. All previous venture firms, including Fletcher Spaght Ventures, Reservoir Venture Partners and Early Stage Partners participated in the round. Also joining the syndicate are new [...]

LineStream Technologies, a software-based control solutions provider, has closed a Series B funding round led by U.S. Venture Partners, joining Series A investor Early Stage Partners. Winston Fu, general partner, and David Liddle, venture partner, of USVP have joined the company’s board of directors. PRESS RELEASE LineStream Technologies Inc., an innovator of software-based control solutions, [...]

OnShift, a maker of web-based staff scheduling and shift management software for healthcare companies, has closed a $3 million Series B round. The round is led by a client of West Capital Advisors and included participation from OnShift’s institutional investors Draper Triangle Ventures, Early Stage Partners and Glengary, the company said in a statement.

CytoPherx Inc., a developer of anti-inflammatory therapy for acute kidney injury, has raised $34 million in funding from Early Stage Partners, ONSET Ventures and Capital Midwest Fund. The money will be used to complete clinical trials and commercialize its therapy product. CytoPherx was founded in July 2007 and is based in Ann Arbor, Michigan.

Early Stage Partners, a Cleveland-based VC firm focused on the Midwest, has closed its second fund with nearly $55 million in capital commitments.